CA9 and neoplasm: In this study, we have chosen the human melanoma system to investigate the hypothesis that SLC-0111, a novel ureido-substituted benzenesulfonamide CAIX inhibitor, may abrogate the pro-survival properties induced in tumour cells by MSC-conditioned medium.